Despite the Indian stock market experiencing sharp volatility last week, the primary market remained robust, with 15 companies making their debut on Dalal Street. This surge in new listings reflects sustained investor interest in new IPOs across various sectors, including financial services and pharmaceuticals.
Mainboard IPOs See Healthy Subscription Levels
The mainboard IPOs received healthy subscription levels, with some issues being oversubscribed by over 100 times across all investor categories. Notable IPOs include ICICI Prudential AMC, Corona Remedies, and Wakefit Innovations.
Corona Remedies and ICICI Prudential AMC See Strong Debuts
Corona Remedies witnessed a solid debut, listing at a 38% premium, while ICICI Prudential AMC saw a 20% premium over its issue price. In contrast, Wakefit Innovations made a muted debut, with shares listing at the issue price.
SME IPOs Dominate Primary Market
10 SME IPOs made their debut, with three listing at premiums of over 20%. KV Toys, HRS Aluglaze, and Exim Routes were among the top performers, with KV Toys listing at a 34% premium over its issue price.
Investor Interest Remains Strong
With 10 more companies lined up to list, the total number of December listings could reach 50. This surge in new listings is a testament to the strong investor interest in the Indian stock market, despite volatility.
Remember, this is a perspective, not a prediction. It's essential to do your own research and consult with certified experts before making any investment decisions.